Skip to main content
TipRanks
Go Ultimate75% OFF

Galectin Therapeutics (GALT) Stock Forecast & Price Target

683 Followers
See the Price Targets and Ratings of:

GALT Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Galectin Therapeutics in the past 3 months

GALT Stock 12 Month Forecast

$11.00▲(269.13% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Galectin Therapeutics in the last 3 months. The average price target is $11.00 with a high forecast of $11.00 and a low forecast of $11.00. The average price target represents a 269.13% change from the last price of $2.98.
Highest Price Target$11.00Average Price Target$11.00Lowest Price Target$11.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GALT
Price TargetArticle
H.C. Wainwright$11buy269.13%UpsideReiterated11/16/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Galectin Therapeutics

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate4/9 ratings generated profit
44%
Average Return
+9.68%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +9.68% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate3/9 ratings generated profit
33%
Average Return
-8.82%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.82% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate3/9 ratings generated profit
33%
Average Return
-8.66%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -8.66% per trade.

GALT Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for GALT
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy42112
Buy00000
Hold00000
Sell00000
Strong Sell00000
total42112

In the current month, GALT has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GALT average Analyst price target in the past 3 months is 11.00.

GALT Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.03
Consensus$-0.03
Low$-0.03

GALT Earnings Forecast

Next quarter’s earnings estimate for GALT is -$0.03 with a range of -$0.03 to -$0.03. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

GALT Sales Forecast

Next quarter’s sales forecast for GALT is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

GALT Stock Forecast FAQ

What is GALT’s average 12-month price target, according to analysts?
Based on analyst ratings, Galectin Therapeutics’s 12-month average price target is $11.00.
What is GALT’s upside potential, based on the analysts’ average price target?
Galectin Therapeutics has 269.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GALT a Buy, Sell or Hold?
Galectin Therapeutics has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Galectin Therapeutics’s price target?
The average price target for Galectin Therapeutics is $11.00. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $11.00, the lowest forecast is $11.00. The average price target represents a 269.13% increase from the current price of $2.98.
What do analysts say about Galectin Therapeutics?
Galectin Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of GALT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.